ArticleClinical cancer research : an official journal of the American Association for Cancer Research2010

Development of a validated immunofluorescence assay for γH2AX as a pharmacodynamic marker of topoisomerase I inhibitor activity.

Robert J Kinders et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.